ursodeoxycholic acid has been researched along with Birth Weight in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Bai, Y; Han, D; Jia, W; Li, D; Lian, S; Lu, D; Ni, D; Pi, Y; Tao, S; Wang, J; Wang, Z; Wu, Y; Ye, H; Zhang, G; Zhang, S; Zhang, X; Zhao, J; Zheng, X; Zou, X | 1 |
Gümüş Güler, B; Özler, S | 1 |
Khan, MN; Middleton, JP; Niccum, M; Syed, S; Vergales, BD | 1 |
Capogna, S; Carroll, R; Ditchik, A; Ferrara, LA; Fox, NS; Kohari, KS | 1 |
Chang, MH; Chen, CY; Chen, HL; Chou, HC; Hsieh, WS; Tsao, PN | 1 |
Carducci, C; Castaño, G; Di Scala, M; Franchi, P; Lemberg, A; Lucangioli, S; Mesquida, M; Sookoian, S; Tripodi, V | 1 |
Hayashi, M; Miyano, T; Nakatsu, N; Nittono, H; Obinata, K; Tokita, A; Watanabe, T | 1 |
7 other study(ies) available for ursodeoxycholic acid and Birth Weight
Article | Year |
---|---|
Gut microbiota-derived ursodeoxycholic acid alleviates low birth weight-induced colonic inflammation by enhancing M2 macrophage polarization.
Topics: Animals; Birth Weight; Colitis; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Inflammation; Mice; Swine; Ursodeoxycholic Acid | 2023 |
Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
Topics: Adult; Alanine Transaminase; Apgar Score; Aspartate-Ammonia Ligase; Bile Acids and Salts; Biomarkers; Birth Weight; Case-Control Studies; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Female; Glypicans; Humans; Postprandial Period; Pregnancy; Pregnancy Complications; Premature Birth; Prospective Studies; Risk Factors; Syndecan-1; Ursodeoxycholic Acid; Young Adult | 2020 |
Cholestasis affects enteral tolerance and prospective weight gain in the NICU.
Topics: Bilirubin; Birth Weight; Cholagogues and Choleretics; Cholestasis; Digestive System Surgical Procedures; Disease Progression; Fat Emulsions, Intravenous; Female; Fibrosis; Fish Oils; Humans; Hyperbilirubinemia; Infant; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Parenteral Nutrition; Postoperative Complications; Prognosis; Retrospective Studies; Ursodeoxycholic Acid; Weight Gain | 2019 |
Outcome after implementation of a modern management strategy for intrahepatic cholestasis of pregnancy.
Topics: Bile Acids and Salts; Birth Weight; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Clinical Protocols; Female; Fetal Monitoring; Gestational Age; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Stillbirth; Ursodeoxycholic Acid; Young Adult | 2017 |
Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.
Topics: Bilirubin; Birth Weight; Case-Control Studies; Cholestasis; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Male; Parenteral Nutrition; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy.
Topics: Adult; Bile Acids and Salts; Biomarkers; Birth Weight; Case-Control Studies; Chenodeoxycholic Acid; Chi-Square Distribution; Cholestasis, Intrahepatic; Cholic Acid; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Deoxycholic Acid; Electrophoresis, Capillary; Female; Gestational Age; Humans; Infant, Newborn; Lithocholic Acid; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, Third; Ursodeoxycholic Acid | 2006 |
Ursodeoxycholic acid therapy in the treatment of biliary atresia.
Topics: Aging; Alanine Transaminase; Aspartate Aminotransferases; Biliary Atresia; Bilirubin; Birth Weight; Deoxycholic Acid; Female; Gestational Age; Humans; Infant; Infant, Newborn; Male; Ursodeoxycholic Acid | 1989 |